Guan-Jun Dong (Guanjun Dong)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Molecular Docking

Transforming Growth Factor

Top Venues

Journal of medicinal chemistry

Biochemistry and cell biology = Biochimie et biologie cellulaire

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Zhang-Xu He, Ge Gao, Hui Qiao, Guan-Jun Dong, Zengyangzong Dan, Ya-Lan Li, Yu-Ruo Qi, Qian Zhang, Shuo Yuan, Hong-Min Liu, Jianzeng Dong, Wen Zhao, Li-Ying Ma
Discovery of 1,2,4-Triazole-3-thione Derivatives as Potent and Selective DCN1 Inhibitors for Pathological Cardiac Fibrosis and Remodeling. Journal of medicinal chemistry (2024)
Guan-Jun Dong, Jiahui Zuo, Junlin Yu, Jiale Xu, Ge Gao, Guo-Bo Li, Wen Zhao, Bin Yu
Structure-Based Design of the Indole-Substituted Triazolopyrimidines as New EED-H3K27me3 Inhibitors for the Treatment of Lymphoma. Journal of medicinal chemistry (2022)
Guan-Jun Dong, Jiahui Zuo, Junlin Yu, Jiale Xu, Ge Gao, Guo-Bo Li, Wen Zhao, Bin Yu
Structure-Based Design of the Indole-Substituted Triazolopyrimidines as New EED-H3K27me3 Inhibitors for the Treatment of Lymphoma. Journal of medicinal chemistry 66 (1) (2022)
Guan-Jun Dong, Jiahui Zuo, Junlin Yu, Jiale Xu, Ge Gao, Guo-Bo Li, Wen Zhao, Bin Yu
Structure-Based Design of the Indole-Substituted Triazolopyrimidines as New EED-H3K27me3 Inhibitors for the Treatment of Lymphoma. Journal of medicinal chemistry 66 (1) (2022)
Guan-Jun Dong, Jiahui Zuo, Junlin Yu, Jiale Xu, Ge Gao, Guo-Bo Li, Wen Zhao, Bin Yu
Structure-Based Design of the Indole-Substituted Triazolopyrimidines as New EED-H3K27me3 Inhibitors for the Treatment of Lymphoma. Journal of medicinal chemistry 66 (1) (2022)
Guan-Jun Dong, Jia-Le Xu, Yu-Ruo Qi, Zi-Qiao Yuan, Wen Zhao
Critical Roles of Polycomb Repressive Complexes in Transcription and Cancer. International journal of molecular sciences 23 (17) (2022)
Wenjuan Zhou, Guan-Jun Dong, Ge Gao, Zhangxu He, Jiale Xu, Shireen Aziz, Liying Ma, Wen Zhao
Evaluation of HZX-960, a novel DCN1-UBC12 interaction inhibitor, as a potential antifibrotic compound for liver fibrosis. Biochemistry and cell biology = Biochimie et biologie cellulaire 100 (4) (2022)